Doctor profile · Federal record
Dr. GARY PINELESS, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · BANNOCKBURN, IL
- NPI 1700806858
- Accepts Medicare
- MIPS 90.4 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2151 WAUKEGAN RD, SUITE 100
BANNOCKBURN, IL 600151885
(847) 444-5300
fax (847) 267-0694
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- October 6, 2020
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Illinois #36068890
- Medicaid
- IL #36068890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700806858. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,596
Distinct HCPCS
10
Medicare allowed
$203,899
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,130 | 882 | $8 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 806 | 481 | $8 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 798 | 459 | $150 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 215 | 70 | $83 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | 156 | $70 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 133 | 105 | $102 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 107 | 79 | $33 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 81 | 44 | $125 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 46 | 21 | $53 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 23 | $182 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 155. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$2,399
Transactions
96
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $336.36 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $325.86 | |
| Novo Nordisk Inc | 9 | $279.37 | |
| AstraZeneca Pharmaceuticals LP | 14 | $265.31 | |
| Amgen Inc. | 9 | $182.57 | |
| Janssen Pharmaceuticals, Inc | 6 | $178.25 | |
| ABIOMED | 5 | $165.48 | |
| PFIZER INC. | 8 | $134.45 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $103.18 | |
| Merck Sharp & Dohme LLC | 4 | $102.84 | |
| Medtronic, Inc. | 2 | $98.45 | |
| Boston Scientific Corporation | 3 | $85.13 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $63.39 | |
| Lilly USA, LLC | 2 | $34.90 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $22.46 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,832
Patients
1,086
Total drug cost
$625,439
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 579 | 163 | $10,030 |
| Amlodipine Besylate | Generic | 516 | 146 | $6,557 |
| Metoprolol Succinate | Generic | 406 | 122 | $10,911 |
| Ezetimibe | Generic | 381 | 111 | $15,955 |
| Rosuvastatin Calcium | Generic | 354 | 102 | $4,681 |
| Eliquis (Apixaban) | Brand | 310 | 75 | $372,483 |
| Losartan Potassium | Generic | 201 | 54 | $2,886 |
| Bisoprolol Fumarate | Generic | 197 | 57 | $10,164 |
| Spironolactone | Generic | 164 | 50 | $1,602 |
| Entresto (Sacubitril/Valsartan) | Brand | 154 | 34 | $178,451 |